Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

23 May 2023 : Original article  

Safety and Efficacy of 4 mg·kg⁻¹ Sugammadex for Simultaneous Pancreas-Kidney Transplantation Recipients: A Prospective Randomized Trial

Jiancheng Tang ORCID logo12ABCDEFG, Rongzhi He2ABCEF, Lei Zhang ORCID logo3ABD, Shiyuan Xu1ABCDEFG*

DOI: 10.12659/AOT.940211

Ann Transplant 2023; 28:e940211

Table 1 The patient characteristics and details of surgery between the 2 groups.

Group SGroup NP* value
Gender (M: F)13/1112/12
ASA II/III10/109/11
BMI, kg/m27.3±1.528.0±1.7
Education years(12 yr)0/15/51/16/3
Duration of the operation, min488±42491±49
Duration of the anesthesiology, min612±22624±30
Haemodialysis before operation, h33.3±2.534.3±3.0
Cumulative rocuronium dose, mg/kg5.98 (4.57–7.13)6.05 (4.61–7.21)
Spontaneous RR, breaths/min15±214±3
Spontaneous TV, ml/kg7.8±0.57.6±0.2
ETAG (MAC)0.82±0.220.81±0.25
Recovery of TOFr to 0.9, min4.4 (3.5–5.9)49.5 (32.5–61.8)
Duration of PACU stay38±1265±21
Requirement for admission to ICU02 (8.4%)
Returns to the OR00
Supplemental oxygen requirements04 (16.8%)
Pulmonary atelectasis0 (0)2 (8.4%)
Pneumonia1 (4.2%)3 (12.5%)
Hyoxemia1 (4.2%)4 (16.7%)
Volume of urine(ml·kg·h)≥1≥1
Renal graft failure00
Pancreas graft failure00
Graft survival rate100%100%
Data are presented as number (%) or mean±SD (standard deviation, SD), P value
* Chi-square test (2×n) and independent sample t test.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358